Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Cost-Effectiveness Analysis of the Addition of Rituximab to CHOP in Young Patients with Good-Prognsosis Diffuse Large-B-Cell Lymphoma
Clinical Drug Investigation, 28(1):55-65
Lectura recomendada:
Expression of Platelet Surface Receptors and early Changes in Platelet Function in Patients with STEMI Treated with Abciximab and Clopidogrel versus Clopidogrel Alone
American Journal of Cardiovascular Drugs, 7(6):433-439
Lectura recomendada:
Long-Term Treatment with Deferasirox (Exjade®, ICL670), a Once-Daily Oral Iron Chelator, Is Effective in Patients with Transfusion-Dependent Anemias
Varios,
Lectura recomendada:
Umbilical Cord Milking Reduces the Need for Red Cell Transfusions and Improves Neonatal Adaptation in Infants Born at Less than 29 Weeks' Gestation: A Randomised Controlled Trial
Archives of Disease in Childhood. Fetal and Neonatal Edition, 93(1):14-19
Lectura recomendada:
Methylprednisolome-Rituximab Is an Effective Salvage Therapy for Patients with Relapsed Chronic Lymphocytic Leukemia Including those with Unfavorable Cytogenetic Features
Leukemia & Lymphoma, 48(12):2412-2417
Lectura recomendada:
Population Pharmacodynamic Modelling of Aspirin- and Ibuprofen-Induced Inhibition of Platelet Aggregation in Healthy Subjects
Clinical Pharmacokinetics, 47(2):129-137
Lectura recomendada:
Mejora de la Seguridad y Evaluación de los Resultados del Proceso de Anticoagulación Oral Implantado en un Area de Atención Primaria
Revista de Calidad Asistencial, 22(6):287-298
Lectura recomendada:
Safety and Efficacy of Total Dose Infusion of Iron Dextran in Iron Deficiency Anaemia
International Journal of Clinical Practice, 62(3):413-415
Lectura recomendada:
Recombinant Factor VIIa (Eptacog Alfa)
A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders
Biodrugs, 22(2):121-136
Lectura recomendada:
Adjusted Dose Lenalidomide Is Safe and Effective in Patients with Deletion (5q) Myelodysplastic Syndrome and Severe Renal Impairment
Leukemia & Lymphoma, 49(2):346-349